Evidence for conformationally different states of interleukin‐10: binding of a neutralizing antibody enhances accessibility of a hidden epitope

We present the mapping of two anti‐human interleukin‐10 (hIL‐10) antibodies (CB/RS/2 and CB/RS/11) which have been described as binding their antigen cooperatively. The epitopes were identified using hIL‐10‐derived overlapping peptide scans prepared by spot synthesis. To identify residues essential for binding within the two epitopes, each position was replaced by all other L‐amino acids. The epitope‐derived peptides were further characterized with respect to antibody affinity and their inhibition of the antibody–hIL‐10 interaction. One antibody (CB/RS/11) binds to residues which are completely buried in the X‐ray structure of IL‐10. Accessibility of this hidden epitope is enhanced upon binding of the antibody CB/RS/2, which recognizes a discontinuous epitope located nearby. The recognition of the hidden CB/RS/11 epitope, as well as the cooperative binding behaviour of the two antibodies, provides evidence that IL‐10 can adopt a conformational state other than that observed in the crystal structure. Copyright © 1999 John Wiley & Sons, Ltd.

[1]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Wlodawer,et al.  Crystal structure of human interleukin‐10 at 1.6 Å resolution and a model of a complex with its soluble receptor , 1996, Protein science : a publication of the Protein Society.

[3]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[4]  A. Kramer,et al.  Antigen sequence- and library-based mapping of linear and discontinuous protein-protein-interaction sites by spot synthesis. , 1999, Current topics in microbiology and immunology.

[5]  G. Jung,et al.  Epitope mapping: synthetic approaches to the understanding of molecular recognition in the immune system. , 1993, Pharmaceutica acta Helvetiae.

[6]  W. Windsor,et al.  Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor , 1995, Nature.

[7]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[9]  R. de Waal Malefyt,et al.  Expression cloning and characterization of a human IL-10 receptor. , 1994, Journal of immunology.

[10]  H. M. Geysen,et al.  Strategies for epitope analysis using peptide synthesis. , 1987, Journal of immunological methods.

[11]  Y. Liu,et al.  A receptor for interleukin 10 is related to interferon receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Frank.  Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support , 1992 .

[13]  A Wlodawer,et al.  Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. , 1995, Structure.

[14]  A. Chaffotte,et al.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. , 1985, Journal of immunological methods.

[15]  J. Banchereau,et al.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S J Rodda,et al.  Cognitive features of continuous antigenic determinants , 1988, Journal of molecular recognition : JMR.

[17]  P. Allavena,et al.  IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages , 1998, European journal of immunology.

[18]  R. Houghten,et al.  Elucidation of discontinuous linear determinants in peptides. , 1990, Journal of immunology.

[19]  A. Kramer,et al.  Molecular Basis for the Binding Promiscuity of an Anti-p24 (HIV-1) Monoclonal Antibody , 1997, Cell.

[20]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[21]  Bernd Bukau,et al.  Substrate specificity of the DnaK chaperone determined by screening cellulose‐bound peptide libraries , 1997, The EMBO journal.

[22]  P. Linsley,et al.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. , 1993, Journal of immunology.

[23]  J L Sussman,et al.  Protein Data Bank archives of three-dimensional macromolecular structures. , 1997, Methods in enzymology.

[24]  N. Romani,et al.  High Level IL-12 Product ion by Murine Dendrit ic Cells : Upregulation via MHC Class II and CD 40 Molecules and Downregulat ion by IL-4 and IL-10 By , 2003 .

[25]  M. Furue,et al.  B7‐1 expression of Langerhans cells is up‐regulated by proinflammatory cytokines, and is down‐regulated by interferon‐γ or by interleukin‐10 , 1995 .

[26]  J. Schneider-Mergener,et al.  Mapping of the interleukin‐10/interleukin‐10 receptor combining site , 1998, Protein science : a publication of the Protein Society.

[27]  P. Hart,et al.  Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. , 1996, Journal of immunology.

[28]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[29]  L. Aarden,et al.  Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. , 1996, Journal of immunology.

[30]  T. Mosmann,et al.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors , 1991, The Journal of experimental medicine.

[31]  H. Volk,et al.  Neutralizing murine monoclonal anti-interleukin-10 antibodies enhance binding of antibodies against a different epitope. , 1996, Molecular immunology.

[32]  S. Narula,et al.  Characterization of interleukin-10 receptors on human and mouse cells. , 1993, The Journal of biological chemistry.

[33]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..